Advertisement

Oxford, AstraZeneca to resume coronavirus vaccine trial

Oxford, AstraZeneca to resume coronavirus vaccine trial

Updated: September 12, 2020 09:57 AM

LONDON (AP) - Oxford University says trials of a coronavirus vaccine that it is developing with pharmaceutical company AstraZeneca will resume, days after being paused due to a reported side-effect in a patient in the U.K.

Advertisement

The university said in large trials such as this “it is expected that some participants will become unwell and every case must be carefully evaluated to ensure careful assessment of safety.”

It said globally some 18,000 people have received the vaccine as part of the trial.

It would not disclose the illness for reasons of participant confidentiality but insisted that it is “committed to the safety of our participants and the highest standards of conduct in our studies and will continue to monitor safety closely.”

Pauses in drug trials are commonplace.

Copyright 2020 The Associated Press. All rights reserved.

Advertisement
Advertisement

Duluth students, parents hold movement against limiting activities

Superior Council wants BNSF to resume paying residents for dust removal

CO v. COVID: Why carbon monoxide detectors are a must this winter

New app will help Duluth police access help with mental health

Local car and hardware shops give advice on snow preparations

Snowy, slippery evening commute Tuesday

Advertisement
Advertisement
Advertisement